SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-06-21 11:33
Tx date 2022-06-20 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+35,000 vol 		160,000
Filed 2021-03-10 11:05
Tx date 2021-03-08 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+25,000 vol 		125,000
Filed 2021-01-07 13:21
Tx date 2020-08-19 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-18,000 vol 		100,000
Filed 2020-03-10 09:51
Tx date 2020-03-06 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+25,000 vol 		118,000
Filed 2020-02-26 09:57
Tx date 2019-12-16 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-10,000 vol 		0
Filed 2020-02-26 09:56
Tx date 2019-05-20 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-30,000 vol 		68,000
Filed 2019-06-09 12:03
Tx date 2019-06-06 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+25,000 vol 		123,000
Filed 2018-10-22
Tx date 2018-10-18 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Holder: with spouse as tenants in common (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$1,410
+3,000 vol
$0.47 each 		111,000
Filed 2018-10-22
Tx date 2018-10-18 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Holder: with spouse as tenants in common (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$1,320
+3,000 vol
$0.44 each 		108,000
Filed 2018-09-14
Tx date 2018-09-11 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Holder: with spouse as tenants in common (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$2,800
+5,000 vol
$0.56 each 		105,000
Filed 2018-04-16
Tx date 2018-03-11 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-25,000 vol 		78,000
Filed 2018-04-16
Tx date 2018-04-12 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+20,000 vol 		98,000
Filed 2017-06-02
Tx date 2017-05-30 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+15,000 vol 		103,000
Filed 2017-05-16
Tx date 2017-05-12 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Holder: with spouse as tenants in common (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-900,000 vol 		100,000
Filed 2017-05-16
Tx date 2017-05-12 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-792,000 vol 		88,000
Filed 2017-05-16
Tx date 2017-05-12 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation
-90,000 vol 		10,000
Filed 2017-05-16
Tx date 2017-05-12 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Holder: with spouse as tenants in common (Indirect Ownership)
Warrants
37 - Stock split or consolidation
-187,500 vol 		20,833
Filed 2017-04-18
Tx date 2017-04-13 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Holder: with spouse as tenants in common (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership
+569,999 vol 		1,000,000
Filed 2017-04-18
Tx date 2017-04-13 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership
-569,999 vol 		0
Filed 2017-04-18
Tx date 2017-04-13 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Holder: with spouse as tenants in common (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-13,991.6245
-111,665 vol
$0.1253 each 		430,001
Filed 2017-04-13
Tx date 2017-04-11 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Holder: with spouse as tenants in common (Indirect Ownership)
Common Shares
54 - Exercise of warrants 		$15,000
+125,000 vol
$0.12 each 		541,666
Filed 2017-04-13
Tx date 2017-04-11 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
-125,000 vol 		100,000
Filed 2016-11-01
Tx date 2016-10-31 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$1,300
+20,000 vol
$0.065 each 		569,999
Filed 2016-11-01
Tx date 2016-10-31 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-20,000 vol 		880,000
Filed 2016-06-23
Tx date 2016-06-22 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+150,000 vol 		900,000
Filed 2016-06-06
Tx date 2012-07-12 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Holder: with spouse as tenants in common (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-06
Tx date 2016-06-01 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Holder: with spouse as tenants in common (Control or Direction)
Warrants
16 - Acquisition or disposition under a prospectus exemption
+208,333 vol 		208,333
Filed 2016-06-06
Tx date 2016-06-01 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Holder: with spouse as tenants in common (Control or Direction)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$24,999
+416,666 vol
$0.06 each 		416,666
Filed 2016-06-06
Tx date 2012-07-12 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Holder: with spouse as tenants in common (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-08-24
Tx date 2015-08-19 		$VIV
Avivagen Inc. 		Boland, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+200,000 vol 		750,000